The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 778K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

35 articles for H Zheng


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
59
Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases.EBI
Intra-Cellular Therapies
27
9-Dihydroerythromycins as non-antibiotic motilin receptor agonists.EBI
Kosan Biosciences
25
Structure-activity relationships of 9-substituted-9-dihydroerythromycin-based motilin agonists: optimizing for potency and safety.EBI
Kosan Biosciences
7
Nicotinic acid receptor agonists differentially activate downstream effectors.EBI
Arena Pharmaceuticals
5
Synthesis and biological evaluation of novel 5-benzylidenethiazolidine-2,4-dione derivatives for the treatment of inflammatory diseases.EBI
Sichuan University
32
Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors.EBI
Tianjin University of Science and Technology
9
Novel indoline-1- or 3,4-dihydroquinoline-1(2H)-substituted carbothiohydrazides as TPO receptor agonists.EBI
Shanghai Hengrui Pharmaceuticals
5
Synthesis and biological evaluation of oxoindolin-3-ylidene ethyl benzothiohydrazides as non-peptide TPO mimics.EBI
Shanghai Hengrui Pharmaceuticals
1
Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.EBI
Institute of Science
5
Halogenated retinoid derivatives as dual RARα and RXRα modulators for treating acute promyelocytic leukemia cells.EBI
Xiamen University
2
Discovery of Novel PROTAC-Based HPK1 Degraders with High Potency and Selectivity for Cancer Immunotherapy.EBI
Huadong Medicine
2
Design and Evaluation of 3-Phenyloxetane Derivative Agonists of the Glucagon-Like Peptide-1 Receptor.EBI
Huadong Medicine Company Limited
2
The Development of a Highly Potent and Selective Human Toll-like Receptor 2 Agonist: Synthesis and Biological Evaluation of CaLGL-1 and Its Derivatives.EBI
Lanzhou University
39
Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors.EBI
University of North Carolina
19
Discovery of ITI-333, a Novel Orally Bioavailable Molecule Targeting Multiple Receptors for the Treatment of Pain and Other Disorders.EBI
Intra-Cellular Therapies, Inc.
30
Alkyl-substituted N-methylaryl-N'-aryl-4-aminobenzamides: A new series of small molecule inhibitors for Wip1 phosphatase.EBI
Niddk
1
A TNF-α blocking peptide that reduces NF-κB and MAPK activity for attenuating inflammation.EBI
Changchun University of Science and Technology
10
Quinazoline-based hydroxamic acid derivatives as dual histone methylation and deacetylation inhibitors for potential anticancer agents.EBI
Tsinghua University
36
UNC5293, a potent, orally available and highly MERTK-selective inhibitor.EBI
University of North Carolina at Chapel Hill
95
Discovery and Optimization of 2EBI
National Center For Advancing Translational Sciences
11
Naphthacemycins from a EBI
Hebei Medical University
50
Discovery of furyl/thienyl β-carboline derivatives as potent and selective PDE5 inhibitors with excellent vasorelaxant effect.EBI
Shandong University
6
Terpenoids with vasorelaxant effects from the Chinese liverwort Scapania carinthiaca.EBI
Shandong University
21
Design and synthesis of furyl/thineyl pyrroloquinolones based on natural alkaloid perlolyrine, lead to the discovery of potent and selective PDE5 inhibitors.EBI
Shandong University
6
Synthesis and biological evaluation of 6-hydroxyl C-aryl glucoside derivatives as novel sodium glucose co-transporter 2 (SGLT2) inhibitors.EBI
Shandong University
26
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition.EBI
Effector Therapeutics
45
Discovery of Potent Orally Active Protease-Activated Receptor 1 (PAR1) Antagonists Based on Andrographolide.EBI
Shandong University
40
NOVEL COMPOUNDSBDB
Sitryx Therapeutics
92
Zaindole derivatives and their use as ERK kinase inhibitorsBDB
Agv Discovery
21
Kinase inhibitors and their use in cancer therapyBDB
Technische UniversitÄT Dortmund
40
Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activityBDB
Kancera
14
Pyridazinones as DAAO enzyme inhibitorsBDB
Takeda Pharmaceutical
585
Heteroaryl substituted nicotinamide compoundsBDB
Bristol Myers Squibb
5
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic propertiesBDB
University of Michigan
18
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists.BDB
Universita Degli Studi Di Milano